A patient with hemoglobin S and elevated hemoglobin F may either have a serious hemoglobinopathy or a relatively benign condition.
Syndromes associated with hemoglobin S and elevated hemoglobin F:
(1) homozygous hemoglobin S (sickle cell disease)
(2) hemoglobin S and beta0-thalassemia
(3) heterozygous hemoglobin S (sickle cell trait) and hereditary persistence of hemoglobin F (HPHF)
In Blacks the most common form of hereditary persistence of hemoglobin F encountered is the heterozygous deletional trait, which is associated with pancellular (homocellular) distribution of the hemoglobin F.
Findings |
Sickle Cell Disease or Sickle-Thalassemia |
Sickle Cell Trait and Heterozygous HPHF |
clinical |
symptomatic, often from a young age |
benign |
percent hemoglobin F |
5 to 30% |
20 to 40% |
distribution of hemoglobin F in RBCs |
heterocellular |
homocellular |
The presence of sickle cell trait and the nondeletional form of hemoglobin F would give a hemoglobin F level comparable to sickle cell disease or sickle-thalassemia. It could also show a heterocellular distribution of hemoglobin F. However, it would have a relatively benign course.
Specialty: Hematology Oncology, Clinical Laboratory
ICD-10: ,